| tipas : |
Žurnalas |
| interneto nuorodą : |
https://doi.org/10.1016/j.ijpharm.2023.123643 |
|
| Mokslinių tyrimų Komandos : |
Padoue - Department of Pharmaceutical and Pharmacological Sciences, University of Padua |
| Autoriai : |
Carpanese D, Rossi V, Di Paolo V, Quintieri L, Penna Zuccolotto G, Sebellin J, Saran C, Pipitone F, Miolo G, de Diana E et al. |
| Pavadinimas : |
Prolonging the stability of cetuximab (Erbitux®) and panitumumab (Vectibix®): An orthogonal assessment of physicochemical, biological and microbiological properties of original opened glass vials and diluted saline preparations. |
| Numeris : |
Int J Pharm ; 649: 123643. 2024 |
|
| Įrodymų lygis : |
|
| fizinis stabilumas : |
|
| Cheminis stabilumas : |
|
| Kiti metodai : |
|
| Komentarai : |
| Baltymai: biologinis aktyvumas ląstelės kultūroje |
|
Junginių sąrašas
 Cetuximab
|
 |
 |
 |
 |
5 mg/ml |
2-8°C |
 |
| 180 |
 |
|
|
|
 |
 |
1,5 & 4 mg/ml |
2-8°C |
|
| 30 |
|
|
|
|
|
|
1,5 & 4 mg/ml |
25°C |
|
| 15 |
 |
|
|
|
|
Panitumumab
|
|
|
|
|
20 mg/ml |
2-8°C |
|
| 180 |
|
|
|
|
|
|
3 & 6 mg/ml |
2-8°C |
|
| 30 |
|
|
|
|
|
|
3 & 6 mg/ml |
25°C |
|
| 15 |
|
|
|
|
|
